125 related articles for article (PubMed ID: 32875336)
21. Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States.
Kelly SP; Anderson WF; Rosenberg PS; Cook MB
Eur Urol Focus; 2018 Jan; 4(1):121-127. PubMed ID: 29162421
[TBL] [Abstract][Full Text] [Related]
22. [Epidemiology and clinical features of prostate cancer in Japan].
Kakehi Y
Nihon Rinsho; 1998 Aug; 56(8):1969-73. PubMed ID: 9750489
[TBL] [Abstract][Full Text] [Related]
23. The geography of prostate cancer and its treatment in Japan.
Oishi K; Yoshida O; Schroeder FH
Cancer Surv; 1995; 23():267-80. PubMed ID: 7621463
[TBL] [Abstract][Full Text] [Related]
24. Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in Asia.
Kitagawa Y; Namiki M
Asian J Androl; 2015; 17(3):475-80. PubMed ID: 25578935
[TBL] [Abstract][Full Text] [Related]
25. Use of complementary and alternative medicine by patients with localized prostate carcinoma: study at a single institute in Japan.
Yoshimura K; Ichioka K; Terada N; Terai A; Arai Y
Int J Clin Oncol; 2003 Feb; 8(1):26-30. PubMed ID: 12601539
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of age-specific reference range of prostate-specific antigen for Japanese men older than 60 years in mass screening for prostate cancer.
Ito K; Yamamoto T; Kubota Y; Suzuki K; Fukabori Y; Kurokawa K; Yamanaka H
Urology; 2000 Aug; 56(2):278-82. PubMed ID: 10925094
[TBL] [Abstract][Full Text] [Related]
27. Geographic pathology of latent prostatic carcinoma.
Yatani R; Chigusa I; Akazaki K; Stemmermann GN; Welsh RA; Correa P
Int J Cancer; 1982 Jun; 29(6):611-6. PubMed ID: 7107064
[TBL] [Abstract][Full Text] [Related]
28. Clinical-pathological comparison of clinical prostate cancer between Japanese Americans in Hawaii and Japanese living in Japan.
Fukagai T; Shimada M; Yoshida H; Namiki T; Carlile RG
Int J Androl; 2000; 23 Suppl 2():43-4. PubMed ID: 10849493
[TBL] [Abstract][Full Text] [Related]
29. The role of prevalence in the diagnosis of prostate cancer.
Delongchamps NB; Singh A; Haas GP
Cancer Control; 2006 Jul; 13(3):158-68. PubMed ID: 16885911
[TBL] [Abstract][Full Text] [Related]
30. Epidemiologic aspects of latent and clinically manifest carcinoma of the prostate.
Dhom G
J Cancer Res Clin Oncol; 1983; 106(3):210-8. PubMed ID: 6654955
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and characteristics of screen-detected prostate carcinomas at low prostate-specific antigen levels: aggressive or insignificant?
Gosselaar C; Roobol MJ; Schröder FH
BJU Int; 2005 Feb; 95(2):231-7. PubMed ID: 15667646
[TBL] [Abstract][Full Text] [Related]
32. [The significance of early detection for prostate cancer in mass screening].
Kato M; Tammbo M; Yoshimatsu T; Ohta M; Kinjyo M; Noda H; Watanabe K; Miyata A; Murata A; Miura I; Yoneda T; Yoshii M; Okegawa T; Kojima M; Sayama T; Nutahara K; Higashihara E
Nihon Hinyokika Gakkai Zasshi; 2001 Jan; 92(1):23-9. PubMed ID: 11235139
[TBL] [Abstract][Full Text] [Related]
33. Study of latent carcinoma of the prostate by step section technique.
Ratanchandani GT; Chaphekar PM
Indian J Cancer; 1972 Jun; 9(2):112-20. PubMed ID: 4635902
[No Abstract] [Full Text] [Related]
34. Differences between latent and clinical prostate carcinomas: lower cell proliferation activity in latent cases.
Takahashi S; Suzuki S; Takahashi S; Inaguma S; Asamoto M; Shirai T
Prostate; 2006 Feb; 66(2):211-7. PubMed ID: 16173032
[TBL] [Abstract][Full Text] [Related]
35. [Characteristics of screening-detected prostate cancer on health checkup].
Uchida K; Akaza H
Gan To Kagaku Ryoho; 1998 Aug; 25(10):1527-32. PubMed ID: 9725044
[TBL] [Abstract][Full Text] [Related]
36. [Etiology of prostate cancer and significance of screening for early prostate cancer].
Imai K; Fukabori Y; Yamanaka H
Gan To Kagaku Ryoho; 1996 Mar; 23(4):403-6. PubMed ID: 8678489
[TBL] [Abstract][Full Text] [Related]
37. Latent carcinoma and atypical lesions of prostate. An autopsy study.
Billis A
Urology; 1986 Oct; 28(4):324-9. PubMed ID: 2429422
[TBL] [Abstract][Full Text] [Related]
38. Is there an association between coronary atherosclerosis and carcinoma of the prostate in men aged 50 years and older? An autopsy and coroner based post-mortem study.
Omalu BI; Hammers JL; Parwani AV; Balani J; Shakir A; Ness RB
Niger J Clin Pract; 2013; 16(1):45-8. PubMed ID: 23377469
[TBL] [Abstract][Full Text] [Related]
39. [Prostate tumor and its diagnosis].
Yamanaka H
Rinsho Byori; 2001 Jul; 49(7):633-7. PubMed ID: 11519121
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of latent prostate carcinoma in two U.S. populations.
Guileyardo JM; Johnson WD; Welsh RA; Akazaki K; Correa P
J Natl Cancer Inst; 1980 Aug; 65(2):311-6. PubMed ID: 6931251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
